FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway

The present study aimed to investigate FSHreceptor binding inhibitor (FRBI) effects on relative factors (K-Ras, c-Myc and Vascular endothelial growth factor (VEGF)) to ovarian cancer, and expression levels of FSH receptor (FSHR) mRNAs and proteins in the cumulus-oocyte complex (COCs), to determine c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Suocheng, Shen, Xiaoyun, Lai, Luju, Liang, Haoqin, Deng, Yingying, Gong, Zhuandi, Che, Tuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976480/
https://www.ncbi.nlm.nih.gov/pubmed/29854294
http://dx.doi.org/10.18632/oncotarget.25139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976480/
https://www.ncbi.nlm.nih.gov/pubmed/29854294
http://dx.doi.org/10.18632/oncotarget.25139

Ejemplares similares